Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06693700

A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.

Conditions

Interventions

TypeNameDescription
OTHERIndoor Air Quality Monitor AirGradient ONEParticipants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs.

Timeline

Start date
2024-11-14
Primary completion
2027-11-14
Completion
2027-11-14
First posted
2024-11-18
Last updated
2025-10-22

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06693700. Inclusion in this directory is not an endorsement.